STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRBP
  4. [EFFECT] Corbus Pharmaceuticals Holdings, Inc. SEC Filing

[EFFECT] Corbus Pharmaceuticals Holdings, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 20, 2026 4:30 P.M.
Form: S-3
CIK: 0001595097
Company Name: Corbus Pharmaceuticals Holdings, Inc.
File Number: 333-294217

Source: View Original Filing on SEC EDGAR

Corbus Pharmaceu

NASDAQ:CRBP

View CRBP Stock Overview →

CRBP Rankings

#4666 Ranked by Market Cap
N/A Ranked by Dividends

CRBP Latest News

Mar 18, 2026
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
Mar 9, 2026
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
Feb 12, 2026
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Jan 5, 2026
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Dec 11, 2025
Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss

CRBP Latest SEC Filings

Mar 25, 2026
[424B3] Corbus Pharmaceuticals Holdings, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 11, 2026
[S-3] Corbus Pharmaceuticals Holdings, Inc. Shelf Registration Statement
Mar 9, 2026
[10-K] Corbus Pharmaceuticals Holdings, Inc. Files Annual Report
Mar 9, 2026
[8-K] Corbus Pharmaceuticals Holdings, Inc. Reports Material Event
Mar 4, 2026
[Form 4] Corbus Pharmaceuticals Holdings, Inc. Insider Trading Activity

CRBP Stock Data

163.88M
16.02M
Biotechnology
Pharmaceutical Preparations
Link
United States
NORWOOD